Orexigen Therapeutics Inc.
48 Wall Street
Suite 1100
New York
New York
10005
Tel: 212-918-4650
Fax: 212-918-4801
Email: contact@biocompartners.com
350 articles about Orexigen Therapeutics Inc.
-
Top Cardiologist Says Diet Drug Maker Orexigen Misled Patients And Investors
5/13/2015
-
Takeda Threatens to End Orexigen Partnership Over Stopped Obesity Study
5/13/2015
-
Orexigen Provides Statement On Termination Of The Light Study And Updates On Contrave Collaboration With Takeda Pharmaceuticals
5/13/2015
-
Orexigen Aborts Required Study For Diet Drug Contrave
5/13/2015
-
Orexigen To Speak At The Bank of America Merrill Lynch Health Care Conference
5/11/2015
-
Orexigen Reports Financial And Business Results For The First Quarter Ended March 31, 2015
5/8/2015
-
Orexigen To Host First Quarter 2015 Financial Results Conference Call
5/5/2015
-
Orexigen Announces Receipt Of Paragraph IV Certification Notice
4/23/2015
-
Orexigen To Speak At The Needham Healthcare Conference
4/13/2015
-
Orexigen Announces That Tom Cannell Has Joined As Chief Commercial Officer
3/30/2015
-
Orexigen's Mysimba Approved In Europe For The Treatment Of Obesity
3/26/2015
-
Orexigen's Failure to Keep a Lid on it Prompts the FDA to Force a Second Study
3/6/2015
-
Did Orexigen Risk Its Future To Boost Stock Price?
3/4/2015
-
Orexigen Therapeutics, Inc. Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2014
2/25/2015
-
Orexigen Therapeutics, Inc. To Speak At The 2015 RBC Capital Markets Global Healthcare Conference
2/23/2015
-
Orexigen Therapeutics, Inc. To Host Full Year And Fourth Quarter 2014 Financial Results Conference Call And Webcast
2/23/2015
-
Orexigen Therapeutics, Inc. To Speak At The Leerink Global Healthcare Conference
2/9/2015
-
Orexigen Therapeutics, Inc. Provides Progress Update on Mysimba European Marketing Authorization
2/9/2015
-
Orexigen Therapeutics, Inc. To Present At The J.P. Morgan 2015 Healthcare Conference
1/8/2015
-
Orexigen Therapeutics, Inc.'s Mysimba (Naltrexone Hcl / Bupropion Hcl Prolonged Release) Receives Positive CHMP Opinion Recommending Approval For Weight Management In The European Union
12/19/2014